We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VRNA
626
DELISTED
Verona Pharma
VRNA
– –
-36,305
Closed -$530K –
VTYX icon
627
DELISTED
Ventyx Biosciences
VTYX
– –
-134,000
Closed -$737K –
W icon
628
Wayfair
W
$14.5B
– –
-4,000
Closed -$272K –
WIX icon
629
WIX.com
WIX
$3.2B
– –
-2,500
Closed -$344K –
XBI icon
630
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
– –
-90,000
Closed -$232K –
XENE icon
631
Xenon Pharmaceuticals
XENE
$3.53B
– –
-7,987
Closed -$344K –
ZS icon
632
Zscaler
ZS
$38.1B
– –
-20,000
Closed -$3.85M –
ZYME icon
633
Zymeworks
ZYME
$1.85B
– –
-54,457
Closed -$573K –
AVBP icon
634
ArriVent BioPharma
AVBP
$825M
– –
-26,181
Closed -$468K –
BOLD icon
635
Boundless Bio
BOLD
$58.5M
– –
-41,650
Closed -$594K –
PHYT icon
636
DELISTED
Pyrophyte Acquisition Corp.
PHYT
– –
-159,438
Closed -$1.77M –
SILK icon
637
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-90,556
Closed -$1.66M –
AIRC icon
638
DELISTED
Apartment Income REIT Corp.
AIRC
– –
-46,425
Closed -$1.51M –
COOLW icon
639
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
– –
-75,251
Closed -$13.2K –
APCA icon
640
DELISTED
AP Acquisition Corp
APCA
– –
-187,581
Closed -$2.12M –
DCPH icon
641
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-151,796
Closed -$2.39M –
ERF icon
642
DELISTED
Enerplus Corporation
ERF
– –
-810,000
Closed -$15.9M –
PUCKW icon
643
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
– –
-283,281
Closed -$3.46K –
OSI icon
644
DELISTED
Osiris Acquisition Corp.
OSI
– –
-55,585
Closed -$589K –
SP icon
645
DELISTED
SP Plus Corporation
SP
– –
-298,558
Closed -$15.6M –
SCRM icon
646
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
– –
-1,719,492
Closed -$18.4M –
CONXW icon
647
DELISTED
CONX Corp. Warrant
CONXW
– –
-316,890
Closed -$55.5K –
PXD icon
648
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-2,431,644
Closed -$638M –
TCN icon
649
DELISTED
Tricon Residential Inc.
TCN
– –
-1,000,000
Closed -$11.2M –
DSAQ icon
650
DELISTED
Direct Selling Acquisition Corp.
DSAQ
– –
-160,685
Closed -$1.78M –

Similar funds

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.